TIS 0.00% 0.0¢ tissue therapies limited

Ann: CEO's Presentation AGM 2014, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 322 Posts.
    lightbulb Created with Sketch. 67
    It is a legal process but I suspect the company would intend to relabel but not sell that product into the european market as part of CE approval eg south africa, russia etc.

    It is a commercial decision at the time and subject to costs charged from the vendor to relabel vs new product costs.

    If you want want the same communication level as a top50 company you have to pay some pretty big legal and admin bills and have lots of staff. For a company with cap of $83M I am happy for main resources to go toward getting approval and to get selling.

    I think the AGM was good and as a paranoid accountant I am happy with the risk at this stage and now understand better why the company went the CE proir to the increased regulation that has occured in last three years.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.